EU signs supply deal with J&J on potential COVID-19 vaccine

The European Commission said on Wednesday it had signed a contract on behalf of EU states with US drugmaker Johnson & Johnson for the supply of 400 million doses of its COVID-19 vaccine candidate.
The move follows an advance purchase agreement signed by Brussels with Johnson & Johnson earlier in October. 

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy